Skip to main content
. Author manuscript; available in PMC: 2014 Jan 30.
Published in final edited form as: Breast Cancer Res Treat. 2009 Feb 12;117(3):603–609. doi: 10.1007/s10549-009-0332-2

Table 6.

Adverse events reported at ≥4% frequency from baseline to 1 year

Adverse event Upfront (N = 267) Delayed ( = 274) P value
Fever 18 (6%)  1 (0%) 0.0001
Creatinine 10 (4%)  3 (1%) 0.045
Limb edema  4 (1%)  0 (0%) 0.042
Fatigue 15 (5%)  6 (2%) 0.038
Nausea 29 (11%) 17 (6%) 0.048
Vomiting 10 (4%)  6 (2%) 0.29
Hot flashes 21 (8%) 27 (10%) 0.42
Myalgia 17 (7%) 14 (5%) 0.53
Arthralgia 34 (13%) 31 (11%) 0.59
Back pain 66 (25%) 64 (23%) 0.67